Search across the website

Find training courses, blog posts, guidelines, knowledge base articles and more.

to navigate esc to close to open
GMP Published

PIC/S 1/95 Pharmaceutical Inspection Co-operation Scheme (PIC Scheme)

Version PIC/S 1/95 (Rev. 7)

Publication
02 Nov 2026
Effective Date
02 Nov 2026
Filename
pics-01-95-rev-7-pic-scheme-eng.pdf
Checksum
d8fb94aaa752e24bf19f77ba2431489e8930c7cb6b91a84ddd117298d6b04c49

Change Summary

Adopted in Istanbul on 2 November 2026 and in force the same day. Narrows the scope from GMDP to GMP, introduces the GMP Regulatory Compliance Programme (GMPRCP) and Participating Organisations, and adds reliance, ATMPs and radiopharmaceuticals.

Main updates: Distribution (GMDP, wholesalers) and contracted QC laboratories dropped from the scope; new term GMPRCP replaces "inspection system" as what members are assessed on; new member category Participating Organisation; mutual reliance and global convergence added to the purpose; ATMPs and radiopharmaceuticals added to the special product categories; governance rewritten under Swiss association law.

Version Change Structure

1) Rationale for the change

PIC/S has not published a reason for dropping distribution. Our reading: the text now matches what PIC/S has always done. Authorities accede and are reassessed on their GMP inspectorates, and even Rev. 6 defined PIC/S as an arrangement "in the field of GMP". Wholesale oversight often sits with a different body, and articles of a Swiss association have to state the purpose precisely. GDP work, including the PIC/S GDP Guide (PE 011), can continue under "other GxP standards or Good Practices applied on a voluntary basis" (para 15(b)).

2) To whom it applies

Regulatory authorities and other inspecting organisations that are PIC/S members or want to join, and the PIC/S Committee, Executive Bureau and Secretariat.

3) To whom it does not apply

Manufacturers and wholesalers directly: the Scheme sets no obligations for companies, and GMP and GDP requirements are unchanged. Training material or SOPs that describe PIC/S as covering "GMDP" are now out of date.

4) The current change description

  • Distribution removed from the scope. Rev. 6 used "Good Manufacturing and Distribution Practice" (GMDP) throughout, mentioned licensing wholesalers in the preamble and covered inspection of "manufacture (or distribution)" in the purpose (para 7(a), 7(d)). Rev. 7 says GMP everywhere (para 8, 15).
  • Contracted QC laboratories removed. Rev. 6 included harmonising the testing of QC laboratories contracted by authorities and training their staff (para 7(d), 12(h)). Rev. 7 drops both.
  • New term: GMPRCP. The "Good Manufacturing Practices Regulatory Compliance Programme" is the whole system an authority uses to secure GMP compliance: inspections plus the legislative, regulatory, organisational and quality system arrangements (para 6). Membership, quality management and reassessment now refer to the GMPRCP instead of the "inspection system" (para 9, 10(d), 11).
  • "Regulatory Authority" replaces "Competent Authority" / "Medicines Regulatory Authority".
  • New member category: Participating Organisation. An organisation other than a regulatory authority that inspects based on legislation and meets "ad-hoc" PIC/S requirements. Unless stated otherwise it is treated as a Participating Authority (para 6).
  • Reliance and convergence. The preamble links PIC/S to inspection reliance and supply resilience; the purpose adds "enabling mutual reliance" and "enhancing global convergence" and collaboration with international harmonisation bodies (para 8(a)).
  • Special product categories. ATMPs and radiopharmaceuticals added to blood and tissue, medicinal gases, hospital pharmacy and biotech products (para 15(g)).
  • Governance under Swiss law. Working language, volunteer status of Committee and Bureau members, delegation, external auditors, a wider Executive Bureau remit, the Directorate, suspension and exclusion of representatives, and allocation of assets on termination.
Newsletter

Get Guideline Updates in Your Mailbox

Subscribe for major GMP/GDP guideline changes, new publications and timeline updates.

We care about your data. Read our privacy policy .